Study of XB010 in Subjects With Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Locally Advanced or Metastatic Solid Tumors · Esophageal Squamous Cell Cancer · Head and Neck Squamous Cell Cancer · NSCLC (Non-small Cell Lung Cancer) · Hormone-receptor-positive Breast Cancer · Triple Negative Breast Cancer (TNBC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States

  • UCLA Department of Medicine - Hematology/Oncology, Los Angeles, California, United States

  • Georgetown University Medical Center, Washington D.C., District of Columbia, United States

  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida, United States

  • Winship Cancer Institute, Atlanta, Georgia, United States

  • University of Chicago Medical Center, Chicago, Illinois, United States

  • Siteman Cancer Center, St Louis, Missouri, United States

  • Montefiore Medical Center - Montefiore Medical Park, The Bronx, New York, United States

  • Carolina BioOncology Institute, Huntersville, North Carolina, United States

  • Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • NEXT Austin, Austin, Texas, United States

  • Baylor University Medical Center, Dallas, Texas, United States

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Inova Schar Cancer, Fairfax, Virginia, United States

  • NEXT Virginia, Fairfax, Virginia, United States

  • University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

  • Sarah Cannon Research Institute London, London, United Kingdom

  • University College London Hospitals NHS Foundation Trust, London, United Kingdom

  • The Christie NHS Foundation Trust, Manchester, United Kingdom

מובילי המחקר
  • Study Director

    Exelixis